Sign In Join Free

growth investing

Latest news and analysis on growth investing

Listed Series

11 high growth ETFs to tip the odds in your favour

Just 4% of US stocks created all the market’s wealth. Here’s how to invest for growth — and manage the bumps along the way.
+7
James Marlay
Livewire Markets
Buy Hold Sell

Buy Hold Sell: 9 ETFs & LITs to build a winning multi-asset portfolio

A winning portfolio needs the right players. We break down 9 ETFs & LITs to help you score on growth, resilience and cash flow.
+6
Buy Hold Sell
Livewire Markets
Equities

Why CSL will likely underperform term deposits

Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s mediocre return.
Chris Leithner
Leithner & Company Ltd
Equities

9 growth and defensive stock picks from 3 market-beating fundies

Plato, Hyperion and Resolution Capital share their top stock ideas to play some of the market's hottest themes.
+7
Vishal Teckchandani
Livewire Markets
Property

Australia’s next hot property markets: 17 suburbs and regions tipped to boom

Here are the top investment property hotspots across the country, chosen for their strong fundamentals, growth potential and current value.
Vishal Teckchandani
Livewire Markets
Buy Hold Sell

Growth stocks are all the rage - here's how to pick the best of the bunch (and 2 ASX examples)

Elston's Joe McCarthy and First Sentier's David Wilson share their tips for hunting great growth stocks, and an example for good measure
Buy Hold Sell
Livewire Markets
Equities

Where the Australian stock market is headed in 2025

There were massive winners and massive losers on the ASX in 2024. We bring you 2025 outlooks from three major brokers: Buy, hold or sell?
+17
Carl Capolingua
Livewire Markets
Outlook Series

The #1 growth stocks set to explode in 2025

Livewire rounded up 10 of Australia's brightest investment minds for their top growth stock picks for the year ahead.
Buy Hold Sell
Livewire Markets
Equities

Are ASX tech highflyers Pro Medicus, Technology One, Wisetech & Xero too high to buy?

Shares of Pro Medicus, Technology One, Wisetech Global and Xero have soared in 2024, but how much upside remains for those who invest now?
+1
Carl Capolingua
Livewire Markets
Equities

Don't avoid quality 'growth'

If the decade past has one message for Australian investors it is not investing in local Growth companies doesn't seem the smartest strategy
+31
Rudi Filapek-Vandyck
FNArena
Investment Theme

Emerging markets - the winning equation

Einstein created a formula for the theory of relativity. However not every equation is easily solvable....
Mugunthan Siva
India Avenue
Livewire Live

Nick Griffin: Every industry on the planet will lean into this technology

Artificial intelligence doesn't just affect tech. As Munro Partner's Nick Griffin explains, it affects every industry on the planet.
+3
Ally Selby
Livewire Markets
Equities

Plenty of traps in valuing equities

The average PE multiple for the ASX 100 in 2024 has blown out to 17.3x.
+20
Rudi Filapek-Vandyck
FNArena
The Rules of Investing

The secret to finding stocks you can hold for 20+ years

Plus, should you really hold on for dear life when a stock gets too hot? Learn this and more in this episode of The Rules of Investing.
+7
The Rules of Investing
Livewire Markets
Investment Theme

The holy grail of high growth assets

Structural growth stories are becoming increasingly scarce, narrow and shorter in horizon
Mugunthan Siva
India Avenue
Buy Hold Sell

Buy Hold Sell: 5 of the fastest-growing stocks on the ASX for FY25

In this episode, Marcus Today's Henry Jennings and Market Matters' James Gerrish analyse some of the market's hottest growth stocks.
+2
Buy Hold Sell
Livewire Markets
Buy Hold Sell

Buy Hold Sell: 5 mispriced growth stocks

Is there any value left after global growth's stellar run? You'll find out in this episode of Buy Hold Sell.
+6
Buy Hold Sell
Livewire Markets
Asset Allocation

Why investors are increasingly drawn to impact-focused growth capital

As part of their alternatives portfolio allocations. Learn more.
Adam Tucker
Dragonfly Enviro Capital
Equities

Be greedy when others are fearful: Why now is the time to invest in healthcare

With the healthcare sector in a deep and prolonged downturn, valuations of public and private R&D stage companies are very attractive.
+2
Hashan De Silva
KP Rx
Equities
Sponsored

How to invest in tech when markets are expensive

If we’ve learned anything in the last year, it’s to not underestimate the impact technology has on our future societies, or our portfolios.
+9
Australian Ethical Investment
Australian Ethical
1-20 of 110